InsidersTradesSigma
Track the 명문제약 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are listed on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 명문제약 has logged 3 public disclosures. Market capitalisation: €36.6bn. The latest transaction was filed on 2 July 2026 (Other). Among the most active insiders: 임기섭. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Myungmoon Pharmaceutical es una compañía farmacéutica surcoreana enfocada en el desarrollo y comercialización de medicamentos. Cotiza en el mercado XKRX.